遺伝子治療の世界市場の機会と2032年までの戦略Including:1) 遺伝子治療のタイプ別生殖細胞療法;体細胞療法2) ベクター別:ベクター別:ウイルスベクター、非ウイルスベクター3)エンドユーザー別:バイオ製薬企業、研究機関バイオ製薬企業;研究機関4) 用途別オンコロジー;希少疾患;変形性膝関節症;神経疾患Covering:ノバルティスAG、F.ホフマン・ラ・ロシュLtd、ギリアド・サイエンシズInc、アステラス製薬Inc、バイオジェンIncGene Therapy Global Market Opportunities And Strategies To 2032Including: 1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy2) By Vector: Viral Vector; Non-Viral Vector3) By End Users: Biopharmaceutical Companies; Research Institutes4) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological DisordersCovering: Novartis AG; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Astellas Pharma Inc; Biogen Inc The Business Research Company社の『Gene Therapy Global Market Opportunities And Strategies To 2032』は、戦略家、マーケティング担当者、上級管理職が、COVID-19閉鎖から脱却した世界の遺伝子治療市場を評... もっと見る
サマリーThe Business Research Company社の『Gene Therapy Global Market Opportunities And Strategies To 2032』は、戦略家、マーケティング担当者、上級管理職が、COVID-19閉鎖から脱却した世界の遺伝子治療市場を評価するために必要な重要情報を提供しています。購入の理由 - 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がコロナウイルスからどのような影響を受けているのか、またウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長していくのかを理解することができます。 - 現地のデータと分析に基づき、地域別および国別の戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。 - 最新の市場調査結果に基づいて顧客を理解する。 - 主要な競合他社とのパフォーマンスの比較 - 主要データセット間の関係を活用し、優れた戦略を立てる。 - 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。 説明 遺伝子治療の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社の遺伝子治療市場グローバルレポートは、これらすべての質問とその他多くの質問に回答します。 当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略などを取り上げています。地域別に市場の過去および予測成長を追跡しています。また、同市場をより広範な遺伝子治療市場の文脈に位置づけ、他市場との比較も行っています。 本レポートは以下の章をカバーしています。 - 序論と市場の特徴 遺伝子治療市場に関する定義や解説、市場の対象となるセグメントについて簡単に紹介しています。 - 主要動向 世界の遺伝子治療市場を形成している主要トレンドにハイライトを当てています。また、同市場における今後の展開についても取り上げます。 - 世界市場の種類と成長 世界の過去(2017年~2022年)、予測(2022年~2027年)、(2027年~2032年)市場価値、過去および予測期間における市場の成長を支え、制御する推進要因と阻害要因。 - 地域別分析 地域別の過去(2017-2022年)および予測(2022-2027年)、(2027-2032年)市場価値と成長率、市場シェア比較。 - 市場セグメンテーション 市場における遺伝子治療タイプ別、ベクター別、用途別、エンドユーザー別の市場価値(2017-2032年)と各セグメント別の分析を収録。 - 地域別市場規模と成長 地域別の市場規模(2022年)、過去(2017年~2022年)と予測(2022年~2027年)、(2027年~2032年)の市場価値、地域内の国々の成長と市場シェア比較。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。 - 競争環境 市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。 - 主要なM&A 本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。 - 市場機会と戦略 調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を交えて記述しています。 - 結論と提言 製品・サービスの提供地域、マーケティング戦略、ターゲット層などの観点から、遺伝子治療プロバイダーへの提言を含む。 - 付録 このセクションには、本レポートで使用されているNAICSコード、略語、通貨コードの詳細が含まれています。 対象範囲 対象市場 1) 遺伝子治療タイプ別生殖細胞療法;体細胞療法 2) ベクター別ウイルスベクター;非ウイルスベクター 3) エンドユーザー別バイオ製薬企業、研究機関、その他エンドユーザー 4) アプリケーション別癌、希少疾患、変形性膝関節症、神経疾患 言及された企業ノバルティス;F.ホフマン・ラ・ロシュ;ギリアド・サイエンシズ;アステラス製薬;バイオジェン 国名オーストラリア、中国、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、遺伝子治療指標の比較。 データ区分:国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 当レポートでは、遺伝子治療市場について説明し、歴史的期間と呼ばれる2017-2022年と予測期間と呼ばれる2022-2027年をカバーし、さらに2027-2032年の予測も行っています。本レポートでは、各地域および各地域内の主要経済圏における市場を評価しています。 世界の遺伝子治療市場は、2017年以降15.8%の複合年間成長率(CAGR)で増加し、2022年には約73億7,080万ドルの規模に達した。同市場は、2022年の73億7,080万ドルから2027年には240億2,710万ドルへと26.7%の成長率が見込まれている。その後、2027年からCAGR13.4%で成長し、2032年には450億7,190万ドルに達すると予想される。 歴史的期間の成長は、医薬品研究開発費の増加、官民パートナーシップの増加、政府投資、脊髄性筋萎縮症患者の増加によってもたらされた。過去期間の成長にマイナスの影響を与えた要因は、標的外特異性、細胞へのヌクレオチド送達における課題、ヌクレオチドの不安定性、規制変更による課題、医療アクセスの低さ、償還の課題、コロナウイルスの流行であった。 今後、がん患者の増加、高齢化人口の増加、製薬部門における研究開発費の増加、遺伝子治療への注目の高まりが市場を牽引していくだろう。今後の遺伝子治療市場の成長を阻害する要因としては、遺伝子治療の高コスト、厳しい規制、ロシア・ウクライナ戦争などが挙げられる。 遺伝子治療市場は、ベクターによってウイルスベクターと非ウイルスベクターに区分される。ウイルスベクターは、遺伝子治療市場においてベクター別で最大のセグメントであり、2022年には65億5,570万ドル、市場全体の88.9%を占める。年平均成長率(CAGR)は26.7%で、今後最も急成長するセグメントと予想される。 遺伝子治療市場は、用途別に腫瘍、希少疾患、変形性膝関節症、神経疾患に区分される。がん市場は、遺伝子治療市場の用途別で最大のセグメントであり、2022年には市場全体の44.2%にあたる32億5,820万ドルを占める。神経疾患市場は、CAGR 27.7%で今後最も急成長するセグメントと予想される。 遺伝子治療市場は、エンドユーザー別にバイオ製薬企業、研究機関、その他のエンドユーザーに区分される。遺伝子治療市場のエンドユーザー別ではバイオ製薬企業が最大セグメントで、2022年には38億8,270万ドル、市場全体の52.7%を占める。その他のエンドユーザー市場は、CAGR 27.6%で今後最も急成長するセグメントと予想される。 遺伝子治療市場は、遺伝子治療の種類によって生殖細胞治療と体細胞治療に区分される。体細胞療法は遺伝子治療の種類別で最大のセグメントであり、2022年の市場全体の95.0%にあたる70億220万ドルを占めた。年平均成長率(CAGR)は26.7%で、今後最も急成長が見込まれる分野である。 遺伝子治療市場で最大の地域は北米で、2022年の世界市場の44.6%を占めた。次いで西ヨーロッパ、アジア太平洋、その他の地域と続く。今後、遺伝子治療市場で最も急速に成長する地域は南米と中東で、2022〜2027年のCAGRはそれぞれ44.4%と42.3%である。 世界の遺伝子治療市場は集中しており、大手企業は少数である。同市場における競合企業上位10社は、2021年には市場全体の53.81%を占めている。ノバルティスAGが市場シェア14.57%で最大、次いでF.ホフマン・ラ・ロシュ7.99%、ギリアド・サイエンシズ7.55%、アステラス製薬6.11%、バイオジェン3.81%、ユニキュアNV3.64%、REGENXBIO Inc.3.26%、ブリストル・マイヤーズスクイブ2.84%、バイオマリン・ファーマシューティカルズ2.33%、ジャズ・ファーマシューティカルズ1.71%となっている。 ベクター別の遺伝子治療市場で最大のビジネスチャンスはウイルスベクター市場にあり、2027年までに世界の年間売上高148億6,890万ドルに達するだろう。遺伝子治療市場のアプリケーション別では、2027年までに世界の年間売上高が70億8,000万ドルに達するオンコロジー市場に最大のビジネスチャンスが生まれるだろう。遺伝子治療市場のエンドユーザー別機会上位はバイオ製薬会社市場で、2027年までに88億8300万ドルの世界年間売上高を獲得する。遺伝子治療別の遺伝子治療市場における最大のビジネスチャンスは体細胞治療市場にあり、2027年までに158億3,960万ドルの世界年間売上高を獲得する。遺伝子治療の市場規模が最も拡大するのは米国で、46億1,200万ドルである。 遺伝子治療市場の市場トレンドに基づく戦略には、投資と製造施設の拡大、テトラサイクリン対応自己サイレンシングアデノウイルス(TESSA)技術の使用、細胞・遺伝子治療プラットフォームの立ち上げ、パートナーシップと共同研究、遺伝子編集への注目の高まり、戦略的M&Aなどがある。 遺伝子治療業界で採用されている戦略には、規制当局の承認取得による事業活動の強化、戦略的提携やパートナーシップによる事業活動の強化、戦略的買収による事業能力の拡大、事業拡大による事業能力の強化などがある。 ビジネス・リサーチ・カンパニーは、この機会を活用するため、遺伝子治療企業に対し、製造施設拡張への投資に注力すること、テトラサイクリン対応自己サイレンシングアデノウイルス(TESSA)技術の利用に注力すること、遺伝子編集への注力を高めること、新興市場での拡大を図ること、先進国市場への注力を継続すること、提携・協力に注力すること、M&Aに注力すること、競争力のある価格の製品を提供すること、展示会やイベントに参加すること、B2Bプロモーションを利用し続けること、急成長するエンドユーザーをターゲットにし続けること、急成長するアプリケーションに注力することを推奨している。 目次1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction And Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. Gene Therapy Market Definition And Segmentations 6.4. Market Segmentation By Gene Therapy Type 6.4.1. Germline Therapy 6.4.2. Somatic Cell Therapy 6.5. Market Segmentation By Vector 6.5.1. Viral Vector 6.5.2. Non-Viral Vector 6.6. Market Segmentation By End Users 6.6.1. Biopharmaceutical Companies 6.6.2. Research Institutes 6.6.3. Other End Users 6.7. Market Segmentation By Application 6.7.1. Oncology 6.7.2. Orphan Disease 6.7.3. Knee Osteoarthritis 6.7.4. Neurological Disorders 7. Major Market Trends 7.1. Growing Investments and Manufacturing Facility Expansion 7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology 7.3. Launch Of Cell And Gene Therapy Platforms 7.4. Partnerships And Collaborations 7.5. Rising Focus On Gene Editing 7.6. Strategic Mergers And Acquisitions 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2022 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global Gene Therapy Market Segmentation 9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. Gene Therapy Market, Regional and Country Analysis 10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes Levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific Gene Therapy Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes Levied 11.11.9. Corporate Tax Structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. South Korea Market 11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes Levied 12.2.9. Corporate Tax Structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe Gene Therapy Market: Country Analysis 12.9. UK Market 12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe Gene Therapy Market: Country Analysis 13.9. Russia Market 13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America Gene Therapy Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America Gene Therapy Market: Country Analysis 15.9. Brazil Market 15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 18.1. Company Profiles 18.2. Novartis AG 18.2.1. Company Overview 18.2.2. Products And Services 18.2.3. Business Strategy 18.2.4. Financial Overview 18.3. F. Hoffmann-La Roche AG 18.3.1. Company Overview 18.3.2. Products And Services 18.3.3. Business Strategy 18.3.4. Financial Overview 18.4. Gilead Sciences Inc. 18.4.1. Company Overview 18.4.2. Products And Services 18.4.3. Financial Overview 18.5. Astellas Pharma Inc. 18.5.1. Company Overview 18.5.2. Products And Services 18.5.3. Business Strategy 18.5.4. Financial Overview 18.6. Biogen Inc. 18.6.1. Company Overview 18.6.2. Products And Services 18.6.3. Business Strategy 18.6.4. Financial Overview 19. Key Mergers And Acquisitions 19.1. Rocket Pharmaceuticals Acquired Renovacor 19.2. Eli Lilly Acquired Akouos 19.3. Ginkgo Bioworks Acquired Altar and Circularis 19.4. Solvias Acquired Cergentis 19.5. Novartis Acquired Gyroscope Therapeutics 19.6. FHI Clinical Acquired Triclinium Clinical Development 19.7. WuXi AppTec Acquired OXGENE 20. Pipeline Analysis 20.1. Products In Development 20.2. Approved Products 21. Opportunities And Strategies 21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities 21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities 21.3. Global Gene Therapy Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Gene Therapy Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
SummaryGene Therapy Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene therapy market as it emerges from the COVID-19 shut down. Table of Contents1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction And Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. Gene Therapy Market Definition And Segmentations 6.4. Market Segmentation By Gene Therapy Type 6.4.1. Germline Therapy 6.4.2. Somatic Cell Therapy 6.5. Market Segmentation By Vector 6.5.1. Viral Vector 6.5.2. Non-Viral Vector 6.6. Market Segmentation By End Users 6.6.1. Biopharmaceutical Companies 6.6.2. Research Institutes 6.6.3. Other End Users 6.7. Market Segmentation By Application 6.7.1. Oncology 6.7.2. Orphan Disease 6.7.3. Knee Osteoarthritis 6.7.4. Neurological Disorders 7. Major Market Trends 7.1. Growing Investments and Manufacturing Facility Expansion 7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology 7.3. Launch Of Cell And Gene Therapy Platforms 7.4. Partnerships And Collaborations 7.5. Rising Focus On Gene Editing 7.6. Strategic Mergers And Acquisitions 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2022 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global Gene Therapy Market Segmentation 9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. Gene Therapy Market, Regional and Country Analysis 10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes Levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific Gene Therapy Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes Levied 11.11.9. Corporate Tax Structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. South Korea Market 11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes Levied 12.2.9. Corporate Tax Structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe Gene Therapy Market: Country Analysis 12.9. UK Market 12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe Gene Therapy Market: Country Analysis 13.9. Russia Market 13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America Gene Therapy Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America Gene Therapy Market: Country Analysis 15.9. Brazil Market 15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 18.1. Company Profiles 18.2. Novartis AG 18.2.1. Company Overview 18.2.2. Products And Services 18.2.3. Business Strategy 18.2.4. Financial Overview 18.3. F. Hoffmann-La Roche AG 18.3.1. Company Overview 18.3.2. Products And Services 18.3.3. Business Strategy 18.3.4. Financial Overview 18.4. Gilead Sciences Inc. 18.4.1. Company Overview 18.4.2. Products And Services 18.4.3. Financial Overview 18.5. Astellas Pharma Inc. 18.5.1. Company Overview 18.5.2. Products And Services 18.5.3. Business Strategy 18.5.4. Financial Overview 18.6. Biogen Inc. 18.6.1. Company Overview 18.6.2. Products And Services 18.6.3. Business Strategy 18.6.4. Financial Overview 19. Key Mergers And Acquisitions 19.1. Rocket Pharmaceuticals Acquired Renovacor 19.2. Eli Lilly Acquired Akouos 19.3. Ginkgo Bioworks Acquired Altar and Circularis 19.4. Solvias Acquired Cergentis 19.5. Novartis Acquired Gyroscope Therapeutics 19.6. FHI Clinical Acquired Triclinium Clinical Development 19.7. WuXi AppTec Acquired OXGENE 20. Pipeline Analysis 20.1. Products In Development 20.2. Approved Products 21. Opportunities And Strategies 21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities 21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities 21.3. Global Gene Therapy Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Gene Therapy Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(gene)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |